吸烟与急性呼吸窘迫综合征风险:系统评价与荟萃分析
该系统评价与荟萃分析检索PubMed、EMBASE、Cochrane Library和Web of Science(2000年1月1日至2023年12月31日),纳入26项观察性研究、共36,995例存在ARDS临床危险因素的成人患者。结果显示吸烟与ARDS风险升高显著相关(OR 1.67;95%CI 1.33-2.08;P<0.001),患者自报吸烟史者结果相似(OR 1.78;95%CI 1.38-2.28;P<0.001),而通过检测烟草代谢物(可替宁和NNAL)识别者无显著差异(OR 1.19;95%CI 0.69-2.05;P=0.53)。吸烟组年龄低于对照组(MD -7.15;95%CI -11.58至-2.72;P=0.002),肺外病因亚组吸烟显著升高ARDS发生率(OR 1.85;95%CI 1.43-2.38;P<0.001)。作者认为应全面评估患者吸烟状态,尤其对合并肺外危险因素者有吸烟史者保持警惕。
要点
- 26项观察性研究、36,995例有ARDS临床危险因素的成人中,吸烟与ARDS风险升高相关(OR 1.67;95%CI 1.33-2.08;P<0.001)。
- 患者自报吸烟史与ARDS发生的关联与全部研究结果相似(OR 1.78;95%CI 1.38-2.28;P<0.001)。
- 通过检测烟草代谢物(可替宁和NNAL)识别者,ARDS风险无显著差异(OR 1.19;95%CI 0.69-2.05;P=0.53)。
- 肺外病因亚组中吸烟显著升高ARDS发生率(OR 1.85;95%CI 1.43-2.38;P<0.001)。
- 吸烟组年龄低于对照组(MD -7.15;95%CI -11.58至-2.72;P=0.002)。
适用人群与场景
- 成人患者,存在ARDS临床危险因素且具备吸烟状况资料。
研究设计与关键结果
- 研究类型:系统评价与荟萃分析,纳入26项观察性研究,共36,995例患者。
- 主要结果:吸烟与ARDS风险升高显著相关(OR 1.67;95%CI 1.33-2.08;P<0.001)。
- 患者自报吸烟史与ARDS发生的关联与全部研究结果相似(OR 1.78;95%CI 1.38-2.28;P<0.001)。
- 通过检测烟草代谢物(可替宁和NNAL)识别者,ARDS风险无显著差异(OR 1.19;95%CI 0.69-2.05;P=0.53)。
- 吸烟组年龄低于对照组(MD -7.15;95%CI -11.58至-2.72;P=0.002)。
- 亚组分析:肺外病因亚组中吸烟显著升高ARDS发生率(OR 1.85;95%CI 1.43-2.38;P<0.001)。
- 发表偏倚未影响结论的完整性;敏感性分析进一步支持汇总结果的可靠性。
证据类型、等级与局限
- 证据类型:系统评价与荟萃分析,纳入26项观察性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为应全面评估患者吸烟状态,对有吸烟史者保持警惕,尤其合并其他肺外ARDS危险因素者。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The relationship between smoking and the risk of acute respiratory distress syndrome (ARDS) has been recognized, but the conclusions have been inconsistent. This systematic review and meta-analysis investigated the association between smoking and ARDS risk in adults.
METHODS: The PubMed, EMBASE, Cochrane Library, and Web of Science databases were searched for eligible studies published from January 1, 2000, to December 31, 2023. We enrolled adult patients exhibiting clinical risk factors for ARDS and smoking condition. Outcomes were quantified using odds ratios (ORs) for binary variables and mean differences (MDs) for continuous variables, with a standard 95% confidence interval (CI).
RESULTS: A total of 26 observational studies involving 36,995 patients were included. The meta-analysis revealed a significant association between smoking and an increased risk of ARDS (OR 1.67; 95% CI 1.33-2.08; P < 0.001). Further analysis revealed that the associations between patient-reported smoking history and ARDS occurrence were generally similar to the results of all the studies (OR 1.78; 95% CI 1.38-2.28; P < 0.001). In contrast, patients identified through the detection of tobacco metabolites (cotinine, a metabolite of nicotine, and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL), a metabolite of tobacco products) showed no significant difference in ARDS risk (OR 1.19; 95% CI 0.69-2.05; P = 0.53). The smoking group was younger than the control group (MD - 7.15; 95% CI - 11.58 to - 2.72; P = 0.002). Subgroup analysis revealed that smoking notably elevated the incidence of ARDS with extrapulmonary etiologies (OR 1.85; 95% CI 1.43-2.38; P < 0.001). Publication bias did not affect the integrity of our conclusions. Sensitivity analysis further reinforced the reliability of our aggregated outcomes.
CONCLUSIONS: There is a strong association between smoking and elevated ARDS risk. This emphasizes the need for thorough assessment of patients' smoking status, urging healthcare providers to vigilantly monitor individuals with a history of smoking, especially those with additional extrapulmonary risk factors for ARDS.
参考来源
- Zhang L, Xu J, Li Y, et al. Smoking on the risk of acute respiratory distress syndrome: a systematic review and meta-analysis. Crit Care. 2024. PMID: 38616271. doi:10.1186/s13054-024-04902-6
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。